Danaher Corporation (NYSE:DHR) Stake Cut by Schechter Investment Advisors LLC

Schechter Investment Advisors LLC lessened its stake in Danaher Corporation (NYSE:DHR - Free Report) by 62.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,638 shares of the conglomerate's stock after selling 4,395 shares during the period. Schechter Investment Advisors LLC's holdings in Danaher were worth $541,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Norges Bank acquired a new stake in shares of Danaher during the fourth quarter valued at about $2,130,740,000. GAMMA Investing LLC boosted its position in shares of Danaher by 24,958.2% during the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after buying an additional 1,863,381 shares during the period. Two Sigma Advisers LP raised its holdings in Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after purchasing an additional 1,601,800 shares in the last quarter. Capital World Investors raised its holdings in Danaher by 32.7% during the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after purchasing an additional 1,566,658 shares in the last quarter. Finally, Point72 Asset Management L.P. raised its holdings in Danaher by 460.6% during the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock worth $309,558,000 after purchasing an additional 1,107,998 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Leerink Partners upped their price target on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a report on Wednesday, April 23rd. Finally, Wolfe Research reduced their target price on shares of Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research note on Monday, April 7th. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $248.43.

Danaher Stock Performance

NYSE DHR traded down $5.01 on Tuesday, hitting $192.74. 4,521,829 shares of the company's stock traded hands, compared to its average volume of 3,517,817. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm's 50-day moving average price is $196.06 and its two-hundred day moving average price is $205.89. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70. The firm has a market capitalization of $137.94 billion, a PE ratio of 37.43, a P/E/G ratio of 2.88 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. As a group, analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.66%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Insider Buying and Selling

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president owned 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.20% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.